Mitochondria not only are the cell's main power producers, they are also the chief cooks and bottle washers.
When they get out of whack, the cell can't function normally. In the brain, mitochondrial failure can set the stage for Parkinson's disease, Alzheimer's disease and other forms of neurodegeneration.
Fortunately there is a group of "night watchmen," proteins that monitor mitochondrial function and sound the alarm if a mitochondrion has failed and needs to be replaced.
One of these proteins, called CHIP, is essential for maintaining mitochondrial health. When CHIP is absent or there is not enough of it, nerve cells cannot recover when, for example, a stroke disrupts their supply of oxygen and glucose.
The critical role of CHIP was reported recently in the journal Antioxidants and Redox Signaling by researchers at Vanderbilt University. Their report has spurred efforts to develop CHIP-enhancing drugs to help speed recovery from strokes and following neurosurgery, and prevent development of neurodegenerative disorders.
"If we can do a better job of maintaining these mitochondria ... that's a very, very powerful tool to have," said senior author BethAnn McLaughlin, Ph.D., assistant professor of Neurology and Pharmacology.
Among the major findings the authors uncovered "profound impairments" at both the anatomical and biochemical levels in mice with the CHIP gene deleted, or "knocked out."
They're smaller than their normal littermates, their back legs are weak, and they die young. "They're 30 days old and they look like they're 150," McLaughlin said.
Using a mass spectrometry technique developed by Vanderbilt proteomics pioneer and co-author Dan Liebler, Ph.D., and his colleagues, graduate student Amy Palubinsky confirmed for the first time that CHIP goes to the mitochondria when cells are stressed by lack of oxygen, for example.
She also found that in the absence of CHIP, nerve cells from these animals are much more vulnerable to oxygen and glucose deprivation and are "loaded" with damaged proteins that impair their functioning. Palubinsky is first author on the paper and a Vanderbilt Clinical Neuroscience Scholar.
Palubinsky said the cellular changes seen in the CHIP knockout mice were the same as those her group previously detected in postmortem human samples from people who'd had strokes or "transient ischemic attacks," which interrupt the brain's oxygen and glucose supplies.
"That gives us a new model system to ... look deeper and see what the mechanisms" are," she said.
The Vanderbilt team is now collaborating with medicinal chemist Jason Gestwicki, Ph.D., at the University of California, San Francisco, to test potential CHIP-enhancing drugs he has developed. "We're moving (toward) trying that in cells, (and) in animal models of stroke and Parkinson's disease," McLaughlin said.
They also are working with David Charles, M.D., professor of Neurology at Vanderbilt and a pioneer in deep brain stimulation to relieve symptoms of Parkinson's disease, to develop imaging tests that can pick up changes in the mitochondria before the cells die.
Explore further: Blocking mitochondrial fission: An effective treatment for Parkinson's disease?
Medical Xpress on facebook
Related Stories
Blocking mitochondrial fission: An effective treatment for Parkinson's disease?
Nov 05, 2014
A study led by a researcher from Plymouth University in the UK, has discovered that the inhibition of a particular mitochondrial fission protein could hold the key to potential treatment for Parkinson's Disease (PD).
Scientists find potential target for treating mitochondrial disorders
Mar 27, 2014
Mitochondria, long known as "cellular power plants" for their generation of the key energy source adenosine triphosphate (ATP), are essential for proper cellular functions. Mitochondrial defects are often observed in a variety ...
Mouse model sheds light on role of mitochondria in neurodegenerative diseases
Sep 19, 2014
A new study by researchers at the University of Utah School of Medicine sheds light on a longstanding question about the role of mitochondria in debilitating and fatal motor neuron diseases and resulted in a new mouse model ...
Applying proteomics to Parkinson's
Oct 03, 2014
(Medical Xpress)—Scientists studying two genes that are mutated in an early-onset form of Parkinson's disease have deciphered how normal versions of these genes collaborate to help rid cells of damaged ...
How Alzheimer's peptides shut down cellular powerhouses
Aug 29, 2014
The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered ...
Recommended for you
Researchers pin down genetic pathways linked to CF disease severity
10 minutes ago
Mutation of one gene is all it takes to get cystic fibrosis (CF), but disease severity depends on many other genes and proteins. For the first time, researchers at the UNC School of Medicine have identified genetic pathways ...
Wisdom teeth stem cells can transform into cells that could treat corneal scarring
24 minutes ago
Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye's cornea and could one day be used to repair corneal scarring due to infection or injury, according to researchers at the University ...
Group of experts issues recommendations for NIH on diversity of sex in research
35 minutes ago
A diverse group of experts from academia, industry and advocacy is offering recommendations to the National Institutes of Health (NIH) as the federal research institution works to increase the inclusion of female animal models ...
Psychology professor examines the taste system
1 hour ago
What we view as the sense of taste is actually a combination of smell, taste and texture, with smell playing a major role. A single taste bud can have dozens of receptor cells that send signals of sour, sweet, salty and bitter ...
The next generation of antibiotics might be right under our feet
1 hour ago
The discovery of a new antibiotic called teixobactin was announced by international team of researchers, in January this year. It is the most significant new antibiotic to be discovered in more than 30 ye ...
New assistive equipment to maximize human sensorimotor function
2 hours ago
A prototype for wearable equipment to support human motion has been developed at Hiroshima University, Japan. This wearable equipment, called the Sensorimotor Enhancing Suit (SEnS), enhances sensorimotor ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Mitochondria not only are the cell's main power producers, they are also the chief cooks and bottle washers.
When they get out of whack, the cell can't function normally. In the brain, mitochondrial failure can set the stage for Parkinson's disease, Alzheimer's disease and other forms of neurodegeneration.
Fortunately there is a group of "night watchmen," proteins that monitor mitochondrial function and sound the alarm if a mitochondrion has failed and needs to be replaced.
One of these proteins, called CHIP, is essential for maintaining mitochondrial health. When CHIP is absent or there is not enough of it, nerve cells cannot recover when, for example, a stroke disrupts their supply of oxygen and glucose.
The critical role of CHIP was reported recently in the journal Antioxidants and Redox Signaling by researchers at Vanderbilt University. Their report has spurred efforts to develop CHIP-enhancing drugs to help speed recovery from strokes and following neurosurgery, and prevent development of neurodegenerative disorders.
"If we can do a better job of maintaining these mitochondria ... that's a very, very powerful tool to have," said senior author BethAnn McLaughlin, Ph.D., assistant professor of Neurology and Pharmacology.
Among the major findings the authors uncovered "profound impairments" at both the anatomical and biochemical levels in mice with the CHIP gene deleted, or "knocked out."
They're smaller than their normal littermates, their back legs are weak, and they die young. "They're 30 days old and they look like they're 150," McLaughlin said.
Using a mass spectrometry technique developed by Vanderbilt proteomics pioneer and co-author Dan Liebler, Ph.D., and his colleagues, graduate student Amy Palubinsky confirmed for the first time that CHIP goes to the mitochondria when cells are stressed by lack of oxygen, for example.
She also found that in the absence of CHIP, nerve cells from these animals are much more vulnerable to oxygen and glucose deprivation and are "loaded" with damaged proteins that impair their functioning. Palubinsky is first author on the paper and a Vanderbilt Clinical Neuroscience Scholar.
Palubinsky said the cellular changes seen in the CHIP knockout mice were the same as those her group previously detected in postmortem human samples from people who'd had strokes or "transient ischemic attacks," which interrupt the brain's oxygen and glucose supplies.
"That gives us a new model system to ... look deeper and see what the mechanisms" are," she said.
The Vanderbilt team is now collaborating with medicinal chemist Jason Gestwicki, Ph.D., at the University of California, San Francisco, to test potential CHIP-enhancing drugs he has developed. "We're moving (toward) trying that in cells, (and) in animal models of stroke and Parkinson's disease," McLaughlin said.
They also are working with David Charles, M.D., professor of Neurology at Vanderbilt and a pioneer in deep brain stimulation to relieve symptoms of Parkinson's disease, to develop imaging tests that can pick up changes in the mitochondria before the cells die.
Explore further: Blocking mitochondrial fission: An effective treatment for Parkinson's disease?
Medical Xpress on facebook
Related Stories
Blocking mitochondrial fission: An effective treatment for Parkinson's disease?
Nov 05, 2014
A study led by a researcher from Plymouth University in the UK, has discovered that the inhibition of a particular mitochondrial fission protein could hold the key to potential treatment for Parkinson's Disease (PD).
Scientists find potential target for treating mitochondrial disorders
Mar 27, 2014
Mitochondria, long known as "cellular power plants" for their generation of the key energy source adenosine triphosphate (ATP), are essential for proper cellular functions. Mitochondrial defects are often observed in a variety ...
Mouse model sheds light on role of mitochondria in neurodegenerative diseases
Sep 19, 2014
A new study by researchers at the University of Utah School of Medicine sheds light on a longstanding question about the role of mitochondria in debilitating and fatal motor neuron diseases and resulted in a new mouse model ...
Applying proteomics to Parkinson's
Oct 03, 2014
(Medical Xpress)—Scientists studying two genes that are mutated in an early-onset form of Parkinson's disease have deciphered how normal versions of these genes collaborate to help rid cells of damaged ...
How Alzheimer's peptides shut down cellular powerhouses
Aug 29, 2014
The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered ...
Recommended for you
Researchers pin down genetic pathways linked to CF disease severity
10 minutes ago
Mutation of one gene is all it takes to get cystic fibrosis (CF), but disease severity depends on many other genes and proteins. For the first time, researchers at the UNC School of Medicine have identified genetic pathways ...
Wisdom teeth stem cells can transform into cells that could treat corneal scarring
24 minutes ago
Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye's cornea and could one day be used to repair corneal scarring due to infection or injury, according to researchers at the University ...
Group of experts issues recommendations for NIH on diversity of sex in research
35 minutes ago
A diverse group of experts from academia, industry and advocacy is offering recommendations to the National Institutes of Health (NIH) as the federal research institution works to increase the inclusion of female animal models ...
Psychology professor examines the taste system
1 hour ago
What we view as the sense of taste is actually a combination of smell, taste and texture, with smell playing a major role. A single taste bud can have dozens of receptor cells that send signals of sour, sweet, salty and bitter ...
The next generation of antibiotics might be right under our feet
1 hour ago
The discovery of a new antibiotic called teixobactin was announced by international team of researchers, in January this year. It is the most significant new antibiotic to be discovered in more than 30 ye ...
New assistive equipment to maximize human sensorimotor function
2 hours ago
A prototype for wearable equipment to support human motion has been developed at Hiroshima University, Japan. This wearable equipment, called the Sensorimotor Enhancing Suit (SEnS), enhances sensorimotor ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment